03.06.2024 - Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, today announced that residents of Nova Scotia living with either type 1 or type 2 diabetes who use intensive insulin and meet .
Eagle Asset Management Inc. grew its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,756,216 shares of the medical device company’s stock after acquiring an additional 310,728 shares during the […]
DexCom, Inc. (NASDAQ:DXCM – Get Free Report) EVP Michael Jon Brown sold 652 shares of the business’s stock in a transaction on Friday, May 31st. The shares were sold at an average price of $119.24, for a total value of $77,744.48. Following the transaction, the executive vice president now owns 67,560 shares of the company’s […]
Evoke Wealth LLC acquired a new position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 29,073 shares of the medical device company’s stock, valued at approximately $3,608,000. A number of other […]
United Services Automobile Association acquired a new stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 11,036 shares of the medical device company’s stock, valued at approximately $1,369,000. Several […]